Pacific Biometrics, Inc.

Ticker:	PBMI	1370 Reynolds Avenue
Exchange:	NASDAQ-Small Cap Market	Irvine, California 92614
Industry:	Service	(714) 263-9933

Type of Shares:	Common Shares	Filing Date:	9/6/96
U.S. Shares:	1,700,000	Offer Date:	10/30/96
Non-U.S. Shares:	0	Filing Price:	$4.75
Primary Shares:	1,700,000	Offer Price:	$4.75
Secondary Shares:	0	Gross Spread:	$0.47
Offering Amount:	$8,075,000	Selling:	$0.31
Expenses:	$450,000	Reallowance:
Shares Out After:	3,649,389

Manager	Tier	Phone
Paradise Valley Securities, Inc.	Lead Manager	(602) 953-7980

Auditor: Coopers & Lybrand
	Audited Income	Latest Unaudited Income	Prior Unaudited Income		Balance Sheet
	6/30/96				6/30/96
Revenue:	$1.66			Assets:	$0.84
Net Income:	-$8.31			Liabilities:	$2.22
EPS:	-$2.78			Equity:	-$1.38
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year

Business Description

The company develops diagnostic and laboratory products and provides laboratory services in the fields of cardiovascular disease and osteoporosis laboratory testing. The company's strategy is to focus on the development of cost-effective, non invasive diagnostic tests and improved laboratory techniques in order to achieve early diagnosis, prevention, and therapeutic monitoring. Bone diseases and disorders, including osteoporosis, are a significant health problem worldwide. An estimated 25 million Americans, and more than 75 million persons worldwide, suffer from osteoporosis. Although the National Osteoporosis Foundation estimates that the costs associated with osteoporosis exceed $10 billion annually in the United States, medical intervention usually occurs only after symptoms such as pain or fractures appear and when treatment is generally too late to be effective.

Use of Proceeds

The proceeds from the proposed offering will be used for product development activities, for working capital and general corporate purposes and to repay bridge loans.

Last updated: 12/29/96